Delivering innovation.
Inspiring confidence.

The preferred

partner for you &

your patients!

Get in touch!

We consider 100 years of innovative leadership in medical technology as just the start.

Haselmeier, the drug delivery business of medmix, is a global medical device manufacturer of advanced injection pen systems and autoinjectors, built on a solid foundation of proprietary IP. With over a century of experience, we specialize in the design, development and manufacture of innovative, high-quality devices for subcutaneous self-administration.

Our products are known for their accuracy, safety, reliability, ease of use and convenience, making them the preferred choice for pharmaceutical and biotechnology companies worldwide. At Haselmeier, we don’t just supply devices – we partner with you to improve patient care and streamline drug delivery.

Our Key Figures

1920

Established

~ 280

International employees

>200

Patents granted

4

Manufacturing sites

Our Mission & Vision

Our Mission

Providing innovative
solutions to help millions
of people live healthier
and more confident lives.

Our Vision

To be the preferred partner for pen and autoinjector solutions for pharma and biotech companies worldwide. We approach every project with the highest level of importance, regardless of its size or complexity.

Our Quality Promise

We are committed to delivering the highest quality injection pens for seamless subcutaneous self-administration. We define exceptional quality as devices that are easy to use, safe, and reliable. Our commitment extends beyond our products to every aspect of our service.

From our world-class offerings to our passionate, dedicated team, we ensure excellence in everything we do. We stand by our promises, collaborate closely with our customers, and provide unwavering support every step of the way.

Growth Driver

medmix

With its advanced precision injection molding capabilities and deep expertise in liquid microdosing, medmix brings a wealth of technological capabilities and financial strength to the table.

This formidable combination, coupled with its expansive global footprint, is helping Haselmeier accelerate innovation in healthcare.

Learn more at www.medmix.swiss.

Our Values

Our culture is based on our dedication to our mission and supported by a clear framework of values that guide how we fulfill our responsibilities. We are committed to:

Customer

Focus

We develop, manufacture and market products and solutions that meet our customers’ needs more effectively than the competition.

Trust &

Teamwork

We build trust by an open, honest, and effective collaboration with each other.

Sustainable

Innovation

We bring innovation to life by continuously improving our processes, products, and solutions while ensuring sustainability for the future.

Quality &

Accountability

We strive to produce excellent work. We enjoy solving problems and hold ourselves accountable for solutions which deliver value to our customers.

A century of thinking ahead

2023

medmix signed a Strategic Alliance with AARDEX, the leading global player in digital medication adherence in clinical trials, to reinforce Haselmeier, medmix’ drug delivery business.

2022

Haselmeier launched PiccoJect™, a highly compact, customizable and fully featured two-step autoinjector consisting of only eight parts with a unique design.

2021

medmix was formed as a spin-off of the fastest growing and most profitable business unit, the Applicator Systems (APS) division of the Sulzer Group. medmix (SIX: MEDX) was listed on the stock exchange on September 30, 2021.

2020

Haselmeier was acquired by Sulzer Ltd.

2020

Haselmeier introduced D-Flex™ Connect, its first digital solution as part of the D-Flex™ Ecosystem, launched that same year. The innovation features a smart cap that enables Bluetooth data collection and transmission, providing significant benefits for clinical trials and rapid path to connected commercial devices.

2018

Haselmeier obtained the Manufacturing authorization and GMP certification for assembly and secondary packaging of combination products from the Local Government.

2017

Haselmeier launched the innovative D-Flex™ product platform, bridging the gap between fixed-dose and variable-dose pens. This platform can be configured for several fixed doses and prevents deviations from the set doses.

2014

JuniorSTAR® was launched by Sanofi-Aventis in Germany as a reusable half-unit insulin pen. This product is one of the few half-unit pens available on the market.

INSUPen EZ was launched by Biocon in India as a reusable Insulin pen, based on the Re-Vario™ platform.

2011

Haselmeier launched the Axis-D™ platform, a disposable pen designed for variable, customizable dosages, while the INSUPen® was launched by Biocon in the Indian market.

2009

Sanofi-Aventis launched the TactiPen® as a reusable insulin pen in Germany, while in Japan it is marketed as iTango®. Both pens are based on the Re-Vario™ platform.

2005

Haselmeier developed the reusable pen injector platform i-pen, renamed 2021 in Re-Vario. The BerliPen® areo, the first application of this platform, was launched by Berlin-Chemie in Germany for insulin therapy.

1998

Haselmeier developed Pentek™, a disposable multi-dose fixed-dose autoinjector for applications including low-molecular-weight heparins, featuring a hidden needle design for safe use.

1993

Haselmeier developed and supplied the DIAPEN 1, a fully automatic insulin pen for 1.5 mL cartridges with a hidden needle design, specifically designed to assist needle-phobic patients. For the first time, it was possible to use needles safely.

1977

Haselmeier entered the diabetes market by developing and supplying DIAMATIC, a fully automatic, one-handed autoinjector for disposable insulin syringes.

1963

Haselmeier pioneered the development and production of the semi-automated Diarapid autoinjector for glass insulin syringes, making history as the first drug-delivery device company to bring an autoinjector to market.

1925

Wilhelm Haselmeier developed the Rotanda reusable syringe, simplifying blood transfusions significantly.

1920

Founded in Stuttgart, Germany, Wilhelm Haselmeier GmbH & Co. initially specialized in the development and supply of glass syringes, special syringes, stethoscopes, and diagnostic products for the first few years.

The preferred partner for you & your patients!